Vaccines against hantaviruses

References

• Schmaljohn C, Hjelle B. Hantaviruses: a global disease problem. Emerg. Infect. Dis. 3, 95–104 (1997).
   PubMed Web of Science ®Google Scholar
• Xiao SY, Leduc JW, Chu YK, Schmaljohn CS. Phylogenetic analyses of virus isolates in the genus Hantavirus, family Bunyaviridae. Virology198, 205–217 (1994).
   PubMedGoogle Scholar
• Mertz GJ, Hjelle BL, Bryan RT. Hantavirus infection. Adv Intern. Med. 42, 369–421 (1997).
   Google Scholar
• Niklasson B, Hornfeldt B, Lundkvist A, Bjorsten S, LeDuc J. Teluporal dynamics of Puumalavirus antibody prevalence in voles and of nephropathia epidemica incidence in humans. ArnTiop. Med Hyg: 53, 134–140 (1995).
   Google Scholar
• Lee HW. Hemorrhagic fever with renal syndrome. History of Hantaan virus and epidemiological features. Scand. j Infect. Dis. 36(Suppl.), 82–85 (1982).
   Google Scholar
• Johnson KM. Emerging Viruses in Context: An Overview of Viral Hemorrhagic Fevers in Emerging Viruses Oxford University Press, New York, USA, 46–57 (1993).
   Google Scholar
• Gajdusek DC. Muroid virus nephropathies and muroid viruses of the Hantaan virus group. £and.j Infect. Dis. Suppl. 36, 96–108 (1982).
   PubMedGoogle Scholar
• Lee HW, Lee PW, Johnson KM. Isolation of the etiologic agent of Korean Hemorrhagic fever. j Infect. Dis. 137, 298–308 (1978).
   Google Scholar
• Schmaljohn CS et al Antigenic and genetic properties of viruses linked to hemorrhagic fever with renal syndrome. Science 227, 1041–1044 (1985).
   Google Scholar
• Lee HW, Baek LJ, Johnson KM. Isolation of Hantaan virus, the etiologic agent of Korean hemorrhagic fever, from wild urban rats.j Infect. Dir. 146, 638–644 (1982).
   Google Scholar
• Nurgaleeva RG et al An epidemiological analysis of hemorrhagic fever with renal syndrome morbidity in the Republic of Bashkortostan in 1997. Zh. Mkrobiol Epidemiol Immunobiol 45–49 (1999).
   Google Scholar
• Sohn YM, Rho HO, Park MS, Kim JS, Summers PL. Primary humoral immune responses to formalin inactivated hemorrhagic fever with renal syndrome vaccine (Hantavax): Consideration of active immunization in South Korea. Yonsei Med. 42, 278–284 (2001).
   PubMed Web of Science ®Google Scholar
• Tang YW et al Distribution of hantavirus serotypes Hantaan and Seoul causing hemorrhagic fever with renal syndrome and identification by hemagglutination inhibition assay. j Clin. Nlicrobiol 29, 1924–1927 (1991).
   Google Scholar
• Li YL et al A serotypic study of hemorrhagic fever with renal syndrome in rural China. Am. j Pop. Med. Hyg. 52, 247–251 (1995).
   PubMedGoogle Scholar
• Avsic-Zupanc T, Toney A, Anderson K, Chu YK, Schmaljohn C. Genetic and antigenic properties of Dobrava virus: a unique member of the Hantavirus genus, family Bunyaviridae. j Gen Vim!. 76(Pt 11), 2801–2808 (1995).
   Google Scholar
• Meisel H et al. First case of infection with hantavirus Dobrava in Germany. Euij Clin. Mcmbiol. Infect. Ds. 17, 884–885 (1998).
   PubMedGoogle Scholar
• Sibold C et al Short report: simultaneous occurrence of Dobrava, Puumala andTula Hantaviruses in Slovakia. Am. j Trop. Merl Hyg: 61, 409–411 (1999).
   Google Scholar
• Klempa B et al Distinct Dobrava hantavirus subtypes of Apodemus agrarius and A. flavicoliis are exchanging genetic information through segment reassortment and recombination: Implications for host-specific evolution and adaptation in nature. Submitted (2002).
   Google Scholar
• Avsic-Zupanc T et al Genetic analysis of wild type Dobrava hantavirus in Slovenia: co- existence of two distinct genetic lineages within the same natural focus. j Gen. Vim!. 81 Pt 7, 1747–1755 (2000).
   Google Scholar
• Kruger DH, Ulrich R, Lundkvist AA. Hantavirus infections and their prevention. Maybes. Infect. 3, 1129–1144 (2001).
   Google Scholar
• Ruo SL et al. Retrospective and prospective studies of hemorrhagic fever with renal syndrome in rural China [published erratum appears in Infect. Dir. 171(5), 1386 (1995)1. Infect. Dis. 170, 527–534 (1994).
   Google Scholar
• Nichol ST et al Genetic identification of a hantavirus associated with an outbreak of acute respiratory illness [see comments]. Science 262, 914–917 (1993).
   PubMed Web of Science ®Google Scholar
• Hjelle B et al A novel hantavirus associated with an outbreak of fatal respiratory disease in the southwestern United States: evolutionary relationships to known hantaviruses. Vim!. 68, 592–596 (1994).
   Google Scholar
• Foucar K et al Outbreak of Hantavirus pulmonary syndrome in the southwestern United States. Response of pathologists and other laboratorians. Am. j Clin. Athol 101, S1—S5 (1994).
   Google Scholar
• Hjelle B et al Detection of Muerto Canyon virus RNA in peripheral blood mononuclear cells from patients with hantavirus pulmonary syndrome. j Infect. Dis. 170, 1013–1017 (1994).
   Google Scholar
• Peters CJ, Khan AS. Hantavirus pulmonary syndrome: the new American hemorrhagic fever. Clin. Infect. Dis. 34, 1224–1231 (2002).
   PubMed Web of Science ®Google Scholar
• Lopez N, Padula P, Rossi C, Lazar° ME, Franze-Fernandez MT. Genetic identification of a new hantavirus causing severe pulmonary syndrome in Argentina. Virology220, 223–226 (1996).
   Google Scholar
• Lopez N et al Genetic characterization and phylogeny of Andes virus and variants from Argentina and Chile. Virus Res. 50, 77–84 (1997).
   Google Scholar
• Johnson AM et al Laguna Negra virus associated with HPS in western Paraguay and Bolivia. Virology238, 115–127 (1997).
   Google Scholar
• Vincent MJ et al Hantavirus pulmonary syndrome in Panama: Identification of novel hantaviruses and their likely reservoirs. Virology 277, 14–19 (2000).
   PubMed Web of Science ®Google Scholar
• Calisher CH et al Identification of arboviruses and certain rodent-borne viruses: reevaluation of the paradigm. Emerg. Infect. Dis. 7, 756–757 (2001).
   Google Scholar
• Padula PJ et al Genetic diversity, distribution and serological features of hantavirus infection in five countries in South America. j Clin. Microbial 38, 3029–3035 (2000).
   Google Scholar
• Hjelle B, Glass GE. Outbreak of hantavirus infection in the Four Corners region of the United States in the wake of the 1997–1998 El Nino-southern oscillation. J. Infect. Dis. 181, 1569–1573 (2000).
   Google Scholar
• Hjelle B et al Rapid and specific detection of Sin Nombre virus antibodies in patients with hantavirus pulmonary syndrome by a strip immunoblot assay suitable for field diagnosis. .1. Clip. Mavbiol. 35, 600–608 (1997).
   Google Scholar
• Ferrer JF et al High prevalence of hantavirus infection in Indian communities of the Paraguayan and Argentinean Gran Chaco. Aimj Tivp. Med NT. 59, 438–444 (1998).
   Google Scholar
• Gonzalez LM et al Prevalence of antibodies to Sin Nombre virus in humans living in rural areas of southern New Mexico and western Texas. Virus Res 74, 177–179 (2001).
   Google Scholar
• Niklasson B, Nyman L, Linde A, Grandien M, Dalrymple J. An epidemiological survey of nephropathia epidemica in Sweden. Scam/. Infect. Dis. 15, 239–245 (1983).
   Google Scholar
• Niklasson B et al An epidemiologic study of hemorrhagic fever with renal syndrome in Bashkirtostan (Russia) and Sweden. Arn. Trap. Med. Hyg. 48, 670–675 (1993).
   PubMed Web of Science ®Google Scholar
• Williams RJ et al An outbreak of hantavirus pulmonary syndrome in western Paraguay. Arn. j Trop. Med. Hyg. 57, 274–282 (1997).
   Google Scholar
• Frampton JW, Lanser S, Nichols CR. Sin Nombre virus infection in 1959 [letter]. Lancet 346, 781–782 (1995).
   Google Scholar
• Lee HW, Ahn CN. Development of inactivated vaccine against hemorrhagic fever with renal syndrome. J Korean Soc. Viral. 18, 143–148 (1988).
   Google Scholar
• Chen HX, Luo ZZ, Zhang JJ. Study on epidemiological efficacy and immunologic strategy of vaccines against hemorrhagic fever with renal syndrome. Chinese Public Health (in Chinese)15, 561–568 (1999).
   Google Scholar
• Birkhead GS, Morse DL, Mills IJ, Novick LE New York State's two-dose schedule for measles immunization. Public Health Rep. 106, 338–344 (1991).
   Google Scholar
• Koster F, Hjelle B. The Hantaviruses. In: Infectious Diseases. WB Saunders Co., Philadelphia, USA (2002).
   Google Scholar
• Peters CJ, Simpson GL, Levy H. Spectrum of hantavirus infection: hemorrhagic fever with renal syndrome and hantavirus pulmonary syndrome. Ann. Rev Med. 50, 531–545 (1999).
   Google Scholar
• Mertz GJ, Hjelle B, Williams TM, Koster FT. Host responses in the hantavirus cardiopulmonary syndrome. In: Emergence and Control of Rodent-Borne Viral Diseases (Hantaviral and Arenal Diseases). Elsevier, Paris, France, 133–137 (1999).
   Google Scholar
• Young JC et al The incubation period of hantavirus pulmonary syndrome. Am. J Trop. Med. Hyg. 62, 714–717 (2000).
   Google Scholar
• Duchin JS et al Hantavirus pulmonary syndrome: a clinical description of 17 patients with a newly recognized disease. The Hantavirus Study Group. N Engl. J. Med. 330, 949–955 (1994). with renal syndrome. Frog. Med. Viral. 36, 62–102 (1989).
   Google Scholar
• Lee HW, van der GG. Hemorrhagic fever with renal syndrome. Prog. Med. Virol. 36, 62–102 (1989).
   PubMedGoogle Scholar
• Castillo C, Naranjo J, Sepulveda A, Ossa G, Levy H. Hantavirus pulmonary syndrome due to Andes virus in Temuco, Chile: clinical experience with 16 adults. Chest 120, 548–554 (2001).
   Google Scholar
• Toro J et al An outbreak of hantavirus pulmonary syndrome, Chile, 1997. Emerg. Infect. Dis. 4, 687-694 (1998).
   Google Scholar
• Hjelle B et al Hantaviruses: clinical, microbiologic and epidemiologic aspects. Crit. Rev Clin. Lab. Sci 32, 469–508 (1995).
   PubMed Web of Science ®Google Scholar
• Koster F et al Rapid presumptive diagnosis of hantavirus cardiopulmonary syndrome by peripheral blood smear review. Arn. Clin. Pathol 116, 665–672 (2001).
   Google Scholar
• Levy H, Simpson SQ. Hantavirus pulmonary syndrome. Am. J Respir. Grit. Care Med. 149, 1710–1713 (1994).
   PubMed Web of Science ®Google Scholar
• Zaki SR et al Hantavirus pulmonary syndrome. Pathogenesis of an emerging infectious disease. Am. J Pathol 146, 552 —579 (1995).
   Google Scholar
• Green W et al Tissue distribution of hantavirus antigen in naturally infected humans and deer mice. J Infect. Dis. 177, 1696–1700 (1998).
   Google Scholar
• Kim S et al Localization of Hantaan viral envelope glycoproteins by monoclonal antibodies in renal tissues from patients with Korean hemorrhagic fever H. Am. J Clin. Pathol 100, 398–403 (1993).
   Google Scholar
• Poljak M, Avsic ZT. Immunohistochemical detection of Hantaan virus antigen in renal tissue from patient with hemorrhagic fever with renal syndrome. Nephron 67, 252 (1994).
   PubMed Web of Science ®Google Scholar
• Mori M et al High levels of cytokine-producing cells in the lung tissues of patients with fatal hantavirus pulmonary syndrome. J Infect. Dis. 179, 295–302 (1999).
   Google Scholar
• Davis IC et al Elevated generation of reactive oxygen/nitrogen species in hantavirus cardiopulmonary syndrome. J. Vim'. 76, 8347–8359 (2002).
   Google Scholar
• Plyusnin A et al Puumala hantavirus genome in patients with nephropathia epidemica: correlation of PCR positivity with HLA haplotype and link to viral sequences in local rodents. j Clin. Nlicrobiol. 35, 1090–1096 (1997).
   PubMed Web of Science ®Google Scholar
• Terajima M et al High levels of viremia in patients with the Hantavirus pulmonary syndrome. J Infect. Dis. 180, 2030–2034 (1999).
   Google Scholar
• Bruno P, Hassell LH, Brown J, Tanner W, Lau A. The protean manifestations of hemorrhagic fever with renal syndrome. A retrospective review of 26 cases from Korea. Ann. Intern. Med. 113, 385–391 (1990).
   Google Scholar
• Hjelle B. Hantavirus Pulmonary Syndrome. In: Laboratory Diagnosis of Vim' Infections. Marcel Decker, Inc., New York, USA, 421–442 (1999).
   Google Scholar
• Chu YK et al Cross-neutralization of •hantaviruses with immune sera from experimentally infected animals and from hemorrhagic fever with renal syndrome and hantavirus pulmonary syndrome patients. J. Infect. Dis. 172, 1581–1584 (1995).
   PubMed Web of Science ®Google Scholar
• Zoller L et al Immunoblot analysis of the serological response in Hantavirus infections. J. Med. Vim'. 27, 231–237 (1989).
   Google Scholar
• Jenison S et al Characterization of human antibody responses to four corners hantavirus infections among patients with hantavirus pulmonary syndrome. J. Viral. 68, 3000–3006 (1994).
   PubMed Web of Science ®Google Scholar
• Yamada T et al Antibody responses to Four Corners hantavirus infections in the deer mouse (Peromyscus maniculatus): identification of an immunodominant region of the viral nucleocapsid protein. J. Viral. 69, 1939–1943 (1995).
   PubMed Web of Science ®Google Scholar
• Hjelle B et al Dominant glycoprotein epitope of Four Corners hantavirus is conserved across a wide geographical area. J. Gen. Viral. 75(Pt 11), 2881–2888 (1994).
   Google Scholar
• Torrez-Martinez N et al Bayou virus- associated hantavirus pulmonary syndrome in Eastern Texas: identification of the rice rat, Oryzomyspa/ustris, as reservoir host. Emerg. Infect. Dis. 4, 105–111 (1998).
   Web of Science ®Google Scholar
• Clement J, Heyman P, McKenna P, Colson P, Avsic-Zupanc T The hantaviruses of Europe: from the bedside to the bench. Emerg. Infect. Dis. 3, 205–211 (1997).
   PubMed Web of Science ®Google Scholar
• Clement J, Colson P, Van Ranst M. Dengue versus hantavirus in CNS infections [letter; comment]. Lancet 355, 2163–2164 (2000).
   Google Scholar
• Hooper JW, Li D. Vaccines against hantaviruses. CUI7: Top. IVlicrobiol. Immunol 256, 171–191 (2001).
   Google Scholar
• Schmaljohn CS, Chu YK, Schmaljohn AL, Dalrymple JM. Antigenic subunits of Hantaan virus expressed by baculovirus and vaccinia virus recombinants. J. Viral. 64, 3162–3170 (1990).
   PubMed Web of Science ®Google Scholar
• Yamanishi K et al Development of inactivated vaccine against virus causing haemorrhagic fever with renal syndrome. Vaccine 6, 278–282 (1988).
   Google Scholar
• Hsu TC, Chow LP, Wei HY, Chen CL, Hsu ST A controlled field trial for an evaluation of effectiveness of mouse-brain Japanese encephalitis vaccine. Taiwan Yi. Xue. Hul. Za Zhi. 70, 55–62 (1971).
   PubMedGoogle Scholar
• Acha PN. Rabies vaccine prepared in suckling mouse brain. Bull. Off Int. Epizoot. 67, 439–442 (1967).
   Google Scholar
• Hemachudha T et al, Myelin basic protein as Engl. J. Med. 316, 369–374 (1987).
   Google Scholar
• Cho HW, Howard CR. Antibody responses in humans to an inactivated hantavirus vaccine (Hantavax). Vaccine 17, 2569–2575 (1999).
   PubMed Web of Science ®Google Scholar
• Song G et al Preliminary human trial of inactivated golden hamster kidney cell (GHKC) vaccine against haemorrhagic fever with renal syndrome (HFRS). Vaccine epidemic hemorrhage fever vaccine using.
   Google Scholar
• Hao FY et al. Efficacy test for inactivated epidemic hemorrhage fever vaccine using golden hamsters. Chinese J. Biology 9, 69–72 (1996).
   Google Scholar
• Yu YX, Yao XY, Dong GM, An Q, Li ZR Antibody response of inactivated HERS vaccine to homologous and heterologous types of the virus. Chinese Biology 3, 14— 16 (1990).
   Google Scholar
• Are booster immunisations needed for Immunity. Lancet 355, 561–565 (2000).
   Google Scholar
• Xll X, Ruo SL, McCormick JB, Fisher-Hoch SR Immunity to Hantavirus challenge in Meriones unguiculatur induced by vaccinia-vectored viral proteins. Am J. Trop. Med. Hyg. 47, 397–404 (1992).
   Google Scholar
• Chu YK, Jennings GB, Schmaljohn CS. A vaccinia virus-vectored Hantaan virus vaccine protects hamsters from challenge with Hantaan and Seoul viruses but not Puumala virus." Vim/. 69, 6417–6423 (1995).
   Google Scholar
• Schmaljohn CS, Hasty SE, Dalrymple JM. Preparation of candidate vaccinia-vectored vaccines for haemorrhagic fever with renal syndrome. Vaccine 10, 10–13 (1992).
   Google Scholar
• McClain DJ, Summers PL, Harrison SA, Schmaljohn AL, Schmaljohn CS. Clinical evaluation of a vaccinia-vectored Hantaan virus vaccine. J. Med. Viral. 60, 77–85 (2000).
   Google Scholar
• Ulrich R et al, Chimaeric HBV core particles carrying a defined segment of Puumala hantavirus nucleocapsid protein evoke protective immunity in an animal model. Vaccine 16, 272–280 (1998).
   Google Scholar
• Ulrich R et al New chimaeric hepatitis B virus core particles carrying hantavirus (serotype Puumala) epitopes: immunogenicity and protection against virus challenge. J. Biotechnol 73, 141–153 (1999).
   PubMed Web of Science ®Google Scholar
• Donnelly JJ, Ulmer JB, Liu MA. DNA vaccines. Dev. Biol. Stand. 95, 43–53 (1998).
   PubMedGoogle Scholar
• Hooper JW, Custer DM, Thompson E, •Schmaljohn CS. DNA vaccination with the Hantaan virus M gene protects Hamsters against three of four HERS hantaviruses and elicits a high-titer neutralizing antibody response in Rhesus monkeys. J. Viral. 75, 8469–8477 (2001).
   Google Scholar
• Hooper JW, Kamrud KI, Elgh F, Custer D, Schmaljohn CS. DNA vaccination with hantavirus M segment elicits neutralizing antibodies and protects against Seoul virus infection. Virology 255, 269–278 (1999).
   Google Scholar
• Kamrud KI, Hooper JW, Elgh F, Schmaljohn CS. Comparison of the protective efficacy of naked DNA, DNA-based Sindbis replicon and packaged Sindbis replicon vectors expressing Hantavirus structural genes in hamsters. Virology263, 209–219 (1999).
   PubMed Web of Science ®Google Scholar
• Hooper JW, Larsen T, Custer DM, •Schmaljohn CS. A lethal disease model for hantavirus pulmonary syndrome. Virology 289, 6–14 (2001).
   Google Scholar
• Barry MA, Lai WC, Johnston SA. Protection against mycoplasma infection using expression-library immunization. Nature 377, 632–635 (1995).
   Google Scholar
• Wang M, Pennock DG, Spik KW, Schmaljohn CS. Epitope mapping studies with neutralizing and non-neutralizing monoclonal antibodies to the G1 and G2 envelope glycoproteins of Hantaan virus. Virology 197, 757–766 (1993).
   PubMed Web of Science ®Google Scholar
• Bharadwaj M, Lyons CR, Wortman IA, Hjelle B. Intramuscular inoculation of Sin Nombre hantavirus cDNAs induces cellular and humoral immune responses in BALB/c mice. Vaccine 17, 2836–2843 (1999).
   PubMed Web of Science ®Google Scholar
• Bharadwaj M et al Genetic vaccines protect against Sin Nombre hantavirus in the deer mouse (Peromyscus maniculatus). J. Gen. Viral. 83, 1745–1751 (2002).
   PubMed Web of Science ®Google Scholar
• Bharadwaj M, Nofchissey R, Goade D, •Koster F, Hjelle B. Humoral immuneresponses in the hantavirus cardiopulmonary syndrome. J. Infect. Dis. 182, 43–48 (2000).
   PubMedGoogle Scholar
• Heiskanen T, Lundkvist A, Vaheri A, Lankinen H. Phage-displayed peptide targeting on the Puumala hantavirus neutralization site. J. Viral. 71, 3879–3885 (1997).
   Google Scholar
• Heiskanen T et al Phage-displayed peptides mimicking the discontinuous neutralization sites of puumala Hantavirus envelope glycoproteins. Virology 262, 321–332 (1999).
   Google Scholar